Claudia Andrea Benavente

Title(s)Associate Professor, Pharmaceutical Sciences
SchoolSchool of Pharmacy and Pharmaceutical Sciences
Address101 Theory, Suite 100
Irvine CA 92697-3958
Phone(949) 824-7845
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Oncogenic Roles of UHRF1 in Cancer. Epigenomes. 2024 Jul 01; 8(3). Kim A, Benavente CA. PMID: 39051184; PMCID: PMC11270427.
      View in: PubMed   Mentions: 1  
    2. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer. J Clin Med. 2024 May 26; 13(11). Gu Y, Benavente CA. PMID: 38892831; PMCID: PMC11173155.
      View in: PubMed   Mentions:
    3. Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential. Int J Mol Sci. 2024 Jan 01; 25(1). Chen CC, Benavente CA. PMID: 38203737; PMCID: PMC10779183.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression. Oncogenesis. 2022 Sep 06; 11(1):51. Wu SC, Kim A, Gu Y, Martinez DI, Zocchi L, Chen CC, Lopez J, Salcido K, Singh S, Wu J, Nael A, Benavente CA. PMID: 36068209; PMCID: PMC9448786.
      View in: PubMed   Mentions: 9  
    5. Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation. Cancers (Basel). 2020 Sep 29; 12(10). Guzman F, Fazeli Y, Khuu M, Salcido K, Singh S, Benavente CA. PMID: 33003565; PMCID: PMC7600434.
      View in: PubMed   Mentions: 16  
    6. Single cell transcriptomics of human epidermis identifies basal stem cell transition states. Nat Commun. 2020 08 25; 11(1):4239. Wang S, Drummond ML, Guerrero-Juarez CF, Tarapore E, MacLean AL, Stabell AR, Wu SC, Gutierrez G, That BT, Benavente CA, Nie Q, Atwood SX. PMID: 32843640; PMCID: PMC7447770.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    7. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 2020 Mar; 7(3-4):23-25. Zocchi L, Wu SC, Benavente CA. PMID: 32426419; PMCID: PMC7217136.
      View in: PubMed   Mentions: 2  
    8. Chromatin remodeling protein HELLS is critical for retinoblastoma tumor initiation and progression. Oncogenesis. 2020 Feb 18; 9(2):25. Zocchi L, Mehta A, Wu SC, Wu J, Gu Y, Wang J, Suh S, Spitale RC, Benavente CA. PMID: 32071286; PMCID: PMC7028996.
      View in: PubMed   Mentions: 21  
    9. Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis. Oncotarget. 2018 Aug 24; 9(66):32580-32592. Wu SC, Benavente CA. PMID: 30220967; PMCID: PMC6135688.
      View in: PubMed   Mentions: 9     Fields:    
    10. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Oncotarget. 2018 May 04; 9(34):23505-23518. Zocchi L, Wu SC, Wu J, Hayama KL, Benavente CA. PMID: 29805751; PMCID: PMC5955096.
      View in: PubMed   Mentions: 19     Fields:    
    11. Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development. 2015 Dec 01; 142(23):4092-106. Aldiri I, Ajioka I, Xu B, Zhang J, Chen X, Benavente C, Finkelstein D, Johnson D, Akiyama J, Pennacchio LA, Dyer MA. PMID: 26628093; PMCID: PMC4712833.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    12. Genetically engineered mouse and orthotopic human tumor xenograft models of retinoblastoma. Methods Mol Biol. 2015; 1267:307-17. Benavente CA, Dyer MA. PMID: 25636476.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    13. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol. 2015; 10:547-62. Benavente CA, Dyer MA. PMID: 25621664.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    14. Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression. Oncotarget. 2014 Oct 30; 5(20):9594-608. Benavente CA, Finkelstein D, Johnson DA, Marine JC, Ashery-Padan R, Dyer MA. PMID: 25338120; PMCID: PMC4259422.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    15. Targeting the DNA repair pathway in Ewing sarcoma. Cell Rep. 2014 Nov 06; 9(3):829-41. Stewart E, Goshorn R, Bradley C, Griffiths LM, Benavente C, Twarog NR, Miller GM, Caufield W, Freeman BB, Bahrami A, Pappo A, Wu J, Loh A, Karlström Å, Calabrese C, Gordon B, Tsurkan L, Hatfield MJ, Potter PM, Snyder SE, Thiagarajan S, Shirinifard A, Sablauer A, Shelat AA, Dyer MA. PMID: 25437539; PMCID: PMC4386669.
      View in: PubMed   Mentions: 96     Fields:    Translation:AnimalsCells
    16. Cross-species genomic and epigenomic landscape of retinoblastoma. Oncotarget. 2013 Jun; 4(6):844-59. Benavente CA, McEvoy JD, Finkelstein D, Wei L, Kang G, Wang YD, Neale G, Ragsdale S, Valentine V, Bahrami A, Temirov J, Pounds S, Zhang J, Dyer MA. PMID: 23765217; PMCID: PMC3757242.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    17. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. PLoS One. 2012; 7(7):e42276. Benavente CA, Schnell SA, Jacobson EL. PMID: 22860104; PMCID: PMC3409181.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    18. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012 Jan 11; 481(7381):329-34. Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, Brennan R, Rusch M, Manning AL, Ma J, Easton J, Shurtleff S, Mullighan C, Pounds S, Mukatira S, Gupta P, Neale G, Zhao D, Lu C, Fulton RS, Fulton LL, Hong X, Dooling DJ, Ochoa K, Naeve C, Dyson NJ, Mardis ER, Bahrami A, Ellison D, Wilson RK, Downing JR, Dyer MA. PMID: 22237022; PMCID: PMC3289956.
      View in: PubMed   Mentions: 264     Fields:    Translation:HumansAnimalsCells
    19. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One. 2011; 6(5):e20487. Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL. PMID: 21655214; PMCID: PMC3105069.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    20. NAD in skin: therapeutic approaches for niacin. Curr Pharm Des. 2009; 15(1):29-38. Benavente CA, Jacobson MK, Jacobson EL. PMID: 19149600.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    21. Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free Radic Biol Med. 2008 Feb 15; 44(4):527-37. Benavente CA, Jacobson EL. PMID: 17997992; PMCID: PMC2323356.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    22. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J Oral Maxillofac Surg. 2003 Oct; 61(10):1171-8. Alstergren P, Benavente C, Kopp S. PMID: 14586853.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    23. Subcellular distribution and mitogenic effect of basic fibroblast growth factor in mesenchymal uncommitted stem cells. Growth Factors. 2003 Jun; 21(2):87-94. Benavente CA, Sierralta WD, Conget PA, Minguell JJ. PMID: 14626356.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    Claudia's Networks
    Concepts (139)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California